Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance

Immunology and Cell Biology

Volumn 84, Issue 4, 2006, Pages 390-395

  Lee, Silvia ^a,b   Watson, Mark W ^a   Clark, Ben ^a   Flexman, James P ^a   Cheng, Wendy ^a   French, Martyn A H ^a,b   Price, Patricia ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cytokine response; Hepatitis C virus (HCV); HIV; IFN ; IL 10; IL 4

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PERIPHERAL CIRCULATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CYTOKINES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HIV; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

HEPATITIS C VIRUS;

EID: 33745099320     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2006.01451.x     Document Type: Article

References (30)

1. Brau N. Update on chronic hepatitis C in HIV/HCV co-infected patients: viral interactions and therapy. AIDS 2003 17 : 2279 90.
2. Gonzalez SA Talal AH. Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin. Liver Dis. 2003 23 : 149 66.
3. Valdez H Chowdhry TK Asaad R et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin. Infect. Dis. 2001 32 : 1487 93.
4. Valdez H. Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev. 2002 4 : 157 64.
5. Alatrakchi N Di Martino V Thibault V et al. Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection. AIDS 2004 18 : 121 3.
6. Atamas SP Choi J Yurovsky VV White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996 156 : 435 41.
7. Arinobu Y Atamas SP Otsuka T et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells. Cell. Immunol. 1999 191 : 161 7.
8. Demissie A Abebe M Aseffa A et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J. Immunol. 2004 172 : 6938 43.
9. Lienhardt C Azzurri A Amedei A et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 2002 32 : 1605 13.
10. Foschi FG Gramenzi A Castelli E et al. Soluble CD30 serum level in HCV-positive chronic active hepatitis: a surrogate marker of disease activity? Cytokine 2000 12 : 815 18.
11. Rizzardi GP Barcellini W Tambussi G et al. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome. AIDS 1996 10 : F45 F50.
12. Hultgren C Desombere I Leroux-Roels G et al. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J. Hepatol. 2004 40 : 971 8.
13. Kaplan DE Sugimoto K Ikeda F et al. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 2005 41 : 1365 75.
14. Dheda K Chang JS Breen RA et al. In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2005 172 : 501 8.
15. Takaki A Wiese M Maertens G et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 2000 6 : 578 82.
16. Legrand E Neau D Galperine T et al. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment. J. Infect. Dis. 2002 186 : 302 11.
17. Gramenzi A Andreone P Loggi E et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J. Viral Hepat. 2005 12 : 525 30.
18. Klein SA Dobmeyer JM Dobmeyer TS et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997 11 : 1111 18.
19. Tanaka M Hirabayashi Y Gatanaga H et al. Reduction in interleukin-2-producing cells but not Th1 to Th2 shift in moderate and advanced stages of human immunodeficiency virus type-1-infection: direct analysis of intracellular cytokine concentrations in CD4+ CD8- T cells. Scand. J. Immunol. 1999 50 : 550 54.
20. Douglas SD Durako S Sullivan KE Camarca M Moscicki AB Wilson CM. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin. Diagn. Lab. Immunol. 2003 10 : 399 404.
21. Bergamini A Bolacchi F Cerasari G et al. Lack of evidence for the Th2 predominance in patients with chronic hepatitis C. Clin. Exp. Immunol. 2001 123 : 451 8.
22. Cribier B Schmitt C Rey D Lang JM Kirn A Stoll-Keller F. Production of cytokines in patients infected by hepatitis C virus. J. Med. Virol. 1998 55 : 89 91.
23. Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J. Gen. Virol. 2004 85 : 3173 88.
24. Watson MW Jaksic A Price P et al. Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis. J. Infect. Dis. 2003 188 : 1533 6.
25. Lee S French MA Price P. IL-23 and IFN-gamma deficiency in immunodeficient HIV patients who achieved a long-term increase in CD4 T-cell counts on highly active antiretroviral therapy. AIDS 2004 18 : 1337 40.
26. Dheda K Chang JS Breen RA et al. Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection. AIDS 2005 19 : 1601 6.
27. Seah GT Gao PS Hopkin JM Rook GA. Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 2001 164 : 1016 18.
28. Fletcher HA Owiafe P Jeffries D et al. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 2004 112 : 669 73.
29. Yoo TW Donfield S Lail A Lynn HS Daar ES. Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J. Infect. Dis. 2005 191 : 4 10.
30. Minutello MA Pileri P Unutmaz D et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 1993 178 : 17 25.